Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Healthcare is failing Gen Z - New innovation offers potential 97% saving to NHS
LovedBy, the health technology and consultancy business, today announces the launch of ‘Nudg with Dexcom’ […]
NHS Runs World-first Test into ‘Sci-Fi Like’ Artificial Pancreases
Almost 1,000 adults and children with type 1 diabetes have been given a potentially life-altering […]
More People With Diabetes Set to Benefit From Blood Sugar Monitors as NHS Roll-Out Succeeds
Half of NHS Type 1 diabetes patients in England are now benefiting from the use […]
NHS to Diagnose Thousands of People with Rare Diabetes
Genetic testing on the NHS will spot a rare form of diabetes in thousands of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more